New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 8, 2014
05:50 EDTTWX, VRXStocks with implied volatility movement; TWX VRX
Stocks with implied volatility movement; Time Warner (TWX) 30, Valeant (VRX) 49 according to iVolatility.
News For TWX;VRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 7, 2015
07:01 EDTTWXAllen & Company to hold a conference
Subscribe for More Information
July 5, 2015
16:52 EDTTWXUniversal's 'Jurassic World' leads U.S. weekend box office with $30.9M
Subscribe for More Information
June 28, 2015
15:40 EDTTWXUniversal's 'Jurassic World' leads U.S. weekend box office with $54.2M
For the weekend of June 28, Comcast (CMCSA, CMCSK) subsidiary Universal's "Jurassic World" topped domestic box office charts at $54.2M. Disney's (DIS) "Inside Out" landed in second place with $52.1M, while Universal's "Ted 2" came in third with $32.9M. Time Warner (TWX) subsidiary Warner Bros.' "Max" and Fox's (FOX, FOXA) "Spy" took fourth and fifth place at $12.2M and $7.8M, respectively. Data gathered by Rentrak.
June 26, 2015
16:16 EDTVRXOn The Fly: Top stock stories for Friday
Subscribe for More Information
09:37 EDTVRXValeant unlikely to pursue Zoetis acquisition, CNBC's Faber says
Subscribe for More Information
09:33 EDTVRXValeant made Zoetis approach as courtesy to Ackman, CNBC reports
Subscribe for More Information
09:33 EDTVRXValeant not going to pursue Zoetis acquisition, CNBC's Faber reports
06:06 EDTVRXZoetis downgraded to Market Perform from Outperform at BMO Capital
Subscribe for More Information
06:02 EDTVRXJPMorgan assumes Valeant pays $60/share for Zoetis
JPMorgan analyst Chris Schott believes Zoetis (ZTS) would bring "an attractive, durable, cash-pay business" to Valeant's portfolio should a merger occur. The Wall Street Journal last night reported that Valeant has approached Zoetis regarding a potential takeover. Schott sees the deal being minimally accretive to near-term earnings, and assumes Valeant pays $60 per share for Zoetis, or a 20% premium to Wednesday's closing price. The analyst thinks any offer would include a substantial equity component given Valeant's levered balance sheet following the Salix acquisition. Schott keeps an Overweight rating on Valeant and a Neutral rating on Zoetis.
June 25, 2015
16:13 EDTVRXValeant made preliminary takeover approach to Zoetis, WSJ reports
Valeant Pharmaceuticals (VRX) made a preliminary approach regarding a potential deal to buy Zoetis (ZTS), said The Wall Street Journal, citing people familiar with the matter. The report said it was not clear if Zoetis is open to a sale or what was the company’s reaction to the approach. Zoetis share spiked more than 11% into the close following the report and are up another 1% to $55.95 in after hours trading. Reference Link
15:58 EDTVRXZoetis jumps 11%, halted for circuit breaker after report of Valeant approach
Subscribe for More Information
15:57 EDTVRXValeant made preliminary takeover approach to Zoetis, DJ reports
Subscribe for More Information
June 24, 2015
14:46 EDTTWXHBO deal an early sign of Facebook original content plans, says Brean Capital
Subscribe for More Information
12:27 EDTTWXHBO to offer free episodes of 'Ballers', 'The Brink' on Facebook, Variety says
Subscribe for More Information
June 23, 2015
09:20 EDTVRXValeant and Progenics announces submission of NDA to FDA for RELISTOR
Valeant Pharmaceuticals International (VRX) and Progenics Pharmaceuticals (PGNX) announced that Valeant submitted a New Drug Application, or NDA, to the FDA for RELISTOR, or methylnaltrexone bromide, Tablets for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain.
07:25 EDTVRXPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use